Home
Richard D. Francis, President and CEO: Teva Pharmaceutical Industries TEVA Sell · Filed 25/02/19
Trade details
- Type
- Insider sale
- Amount
- $1,279,826.7
- Shares · price
- 75,506 sh · $16.95 a share
- Held after
- 209,444 sh
- Trade date
- 25/02/18
- Filed
- 25/02/19
- Days to filing
- 1 days
Sold 26.5% of holdings
- Share of holding sold
- 26.5%
Teva Pharmaceutical Industries trades, last 26 weeks
What else happened in Teva Pharmaceutical Industries around then
Filed or reported within 30 days of the trade day · 25/01/19~25/03/20Richard D. Francis's recent trades
- Richard D. Francis
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 planTeva Pharmaceutical Industries
TEVA
$211.4K
6,153 sh
$211.4K
Filed 06/08
Traded 06/05
- Richard D. Francis
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 planTeva Pharmaceutical Industries
TEVA
$211.4K
6,153 sh
$211.4K
Filed 06/05
Traded 06/05
- Richard D. Francis
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 planTeva Pharmaceutical Industries
TEVA
$634.2K
20,025 sh
$634.2K
Filed 03/09
Traded 03/05
- Richard D. Francis
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 planTeva Pharmaceutical Industries
TEVA
$759.3K
23,393 sh
$759.3K
Filed 03/06
Traded 03/04
- Richard D. Francis
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 planTeva Pharmaceutical Industries
TEVA
$634.2K
20,025 sh
$634.2K
Filed 03/05
Traded 03/05